A recent study published in the Journal of Medical Internet Research (JMIR) shows initial support for a new version of Woebot – a text-based chatbot app designed to address mental health issues – that is designed to reduce substance use and other measures tied to substance use disorder (SUD).
Conducted by researchers from Stanford University School of Medicine and Woebot Health, the investigation...
Pharma-related digital health news picked up this week. Boehringer Ingelheim has teamed up with Sutter Health to research COPD interventions; BioDelivery Science created an app to help users deal with prediction opioid addictions; and Canaan Partners' Julie Papanek talked to the Wall Street Journal about pharma's emerging role in digital health.
Boehringer Ingelheim Pharmaceuticals, the...
According to a non-randomized trial of 524 mostly African American teenagers, screenings administered via iPad could help pediatricians to learn about their patients' drug, alcohol, and tobacco use more reliably.
The study, recently published in Pediatrics and conducted in Baltimore, Maryland, tested a new brief screening tool from the National Institute on Alcohol Abuse and Alcoholism -- one...
Similar device: Affectiva's Q Sensor
The promise of some wireless-enabled remote patient monitoring devices is that they can help prevent heart failure episodes. They aim to reduce hospital readmissions. A new device currently being developed by a team of academics here in Massachusetts aims to do the same thing for drug addiction relapses. After 30 days in a substance abuse clinic, can a remote...
